Profusa Invests Additional $1 Million in Digital Treasury Assets
Profusa (Nasdaq: PFSA) announced on October 7, 2025 a second $1 million investment in digital treasury assets as part of its treasury management strategy to hedge macroeconomic uncertainty. The company said the strategy supports commercial and development plans for its Lumee continuous biochemical monitoring platform and aims to maintain capital for AI-driven digital health initiatives. Profusa noted continued collaboration with Ascent Partners Fund, which funded an additional $2 million tranche to establish a low-cost, capital-efficient Bitcoin treasury approach the company views as a digital store of value. Management framed the purchases as a foundation for progressing commercial and clinical programs.
Profusa (Nasdaq: PFSA) ha annunciato il 7 ottobre 2025 un secondo investimento di 1 milione di dollari in asset digitali di tesoreria nell'ambito della sua strategia di gestione della tesoreria mirata a mitigare l'incertezza macroeconomica. L'azienda ha dichiarato che la strategia supporta piani commerciali e di sviluppo per la sua piattaforma di monitoraggio biochimico continuo Lumee e ha come obiettivo mantenere capitale per iniziative di salute digitale guidate dall'IA. Profusa ha sottolineato la continua collaborazione con Ascent Partners Fund, che ha finanziato una tranche aggiuntiva di 2 milioni di dollari per stabilire un approccio a tesoreria Bitcoin a basso costo e ad alta efficienza di capitale, che l'azienda considera una riserva digitale di valore. La direzione ha inquadrato gli acquisti come base per avanzare i programmi commerciali e clinici.
Profusa (Nasdaq: PFSA) anunció el 7 de octubre de 2025 una segunda inversión de 1 millón de dólares en activos digitales de tesorería como parte de su estrategia de gestión de tesorería para mitigar la incertidumbre macroeconómica. La empresa dijo que la estrategia apoya planes comerciales y de desarrollo para su plataforma de monitoreo bioquímico continuo Lumee y tiene como objetivo mantener capital para iniciativas de salud digital impulsadas por IA. Profusa señaló la colaboración continua con Ascent Partners Fund, que financió una tranche adicional de 2 millones de dólares para establecer un enfoque de tesorería Bitcoin de bajo costo y alta eficiencia de capital que la empresa considera una reserva digital de valor. La dirección enmarcó las compras como una base para hacer avanzar programas comerciales y clínicos.
Profusa (나스닥: PFSA)가 2025년 10월 7일 매크로 경제 불확실성에 대응하기 위한 현금 보유전략의 일환으로 디지털 재무자산에 두 번째 100만 달러 투자를 발표했습니다. 회사는 이 전략이 Lumee 연속 생화학 모니터링 플랫폼의 상업 및 개발 계획을 지원하고 IA 주도 디지털 헬스 이니셔티브를 위한 자본을 유지하는 것을 목표로 한다고 밝혔습니다. Profusa는 추가로 Ascent Partners Fund와의 지속적인 협력을 언급했으며, 이는 낮은 비용의 자본 효율적인 비트코인 재무전략을 구축하기 위해 200만 달러의 트랜치를 추가로 제공해 디지털 가치 저장 수단으로 보는 것으로 회사가 해석합니다. 경영진은 이러한 매수를 상업적 및 임상 프로그램의 진행을 위한 기초로 설명했습니다.
Profusa (Nasdaq: PFSA) a annoncé le 7 octobre 2025 un second investissement de 1 million de dollars dans des actifs numériques de trésorerie dans le cadre de sa stratégie de gestion de trésorerie visant à réduire l'incertitude macroéconomique. L'entreprise a déclaré que la stratégie soutient les plans commerciaux et de développement pour sa plateforme de surveillance biochimique continue Lumee et vise à maintenir des liquidités pour les initiatives de santé numérique axées sur l'IA. Profusa a souligné sa collaboration continue avec Ascent Partners Fund, qui a financé une tranche supplémentaire de 2 millions de dollars afin d'établir une approche de trésorerie Bitcoin à faible coût et efficace en capital que l'entreprise considère comme une réserve de valeur numérique. La direction a présenté ces achats comme une base pour faire progresser les programmes commerciaux et cliniques.
Profusa (Nasdaq: PFSA) gab am 7. Oktober 2025 eine zweite Investition von 1 Million US-Dollar in digitale Treasury-Vermögenswerte im Rahmen seiner Treasury-Management-Strategie zur Absicherung gegen makroökonomische Unsicherheiten bekannt. Das Unternehmen erklärte, dass die Strategie kommerzielle und Entwicklungspläne für seine Lumee Plattform zur kontinuierlichen biochemischen Überwachung unterstützt und darauf abzielt, Kapital für KI-gesteuerte digitale Gesundheitsinitiativen bereitzuhalten. Profusa wies auf die fortgesetzte Zusammenarbeit mit Ascent Partners Fund hin, der eine zusätzliche Tranche von 2 Millionen US-Dollar finanziert hat, um einen kostengünstigen, kapitaleffizienten Bitcoin-Treasury-Ansatz zu etablieren, den das Unternehmen als digitales Wertaufbewahrungsmittel betrachtet. Die Geschäftsführung hob die Käufe als Grundlage für den Fortschritt kommerzieller und klinischer Programme hervor.
Profusa (Nasdaq: PFSA) أعلنت في 7 أكتوبر 2025 عن استثمار ثانٍ بقيمة مليون دولار في أصول الخزينة الرقمية كجزء من استراتيجية إدارة الخزينة الخاصة بها للتحوط من عدم اليقين الاقتصادي الكلي. قالت الشركة إن الاستراتيجية تدعم خططها التجارية والتطويرية لمنصة Lumee للمراقبة الكيميائية الحيوية المستمرة وتهدف إلى الحفاظ على رأس المال لمبادرات الصحة الرقمية المدعومة بالذكاء الاصطناعي. أشارت Profusa إلى استمرار التعاون مع Ascent Partners Fund، الذي موّل شريحة إضافية بقيمة 2 ملايين دولار لإنشاء نهج خزانة بيتكوين منخفض التكلفة وكفء رأس المال تعتبره الشركة مخزنًا رقميًا للقيمة. وصفت الإدارة هذه المشتريات بأنها أساس لتقدم البرامج التجارية والسريرية.
Profusa (纳斯达克：PFSA) 于 2025年10月7日 宣布在数字国债资产方面进行第二笔 100万美元 投资，作为其财务管理策略的一部分，用以对冲宏观经济不确定性。公司表示，该策略支持其 Lumee 连续生物化学监测平台的商业与开发计划，并旨在为人工智能驱动的数字健康计划维持资本。Profusa 指出与 Ascent Partners Fund 的持续合作，该基金再投资了 200万美元，以建立一种低成本、资本高效的比特币国债策略，公司将其视为数字价值储存手段。管理层将这些购买描述为推进商业与临床程序的基础。
- Deployed an additional $1M to digital treasury on Oct 7, 2025
- Ascent Partners funded a $2M tranche for treasury strategy
- Increased exposure to Bitcoin market price volatility
- Allocated cash to digital assets rather than operational uses
BERKELEY, Calif, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, announces its second
“We believe the continued execution of our digital asset strategy helps ensure that we are prudently managing our resources to continue to support both our commercial and development plans for our Lumee platform technology. Our digital treasury strategy is designed to facilitate that we maintain sufficient capital to provide the best-in-class, AI-driven digital health platform for the benefit of chronic disease and health and wellness management. We continue to collaborate with Ascent Partners Fund, which funded our second tranche of
About Profusa
Based in Berkeley, Calif., Profusa is a commercial stage digital health company led by visionary scientific founders, an experienced management team and a world-class board of directors in the development of a new generation of tissue-integrated sensors to detect and continuously transmit actionable, medical-grade data for personal and medical use. With its long-lasting, injectable and affordable biosensors and its intelligent data platform, Profusa aims to provide people with a personalized biochemical signature rooted in data that clinicians can trust and rely on.
“LUMEE”, “PROFUSA” and the PROFUSA logo are registered trademarks of Profusa Inc. in the United States, Canada, European Union, China, Japan, South Korea and Australia.
For more information, visit https://profusa.com.
Special Note Regarding Forward-Looking Statements
Certain statements in this press release (this “Press Release”) may be considered “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or future financial or operating performance of Profusa. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “propose,” “seek,” “should,” “strive,” “will,” or “would” or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which may be beyond the control of Profusa and could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Profusa and its management are inherently uncertain. Profusa cautions you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. There are risks and uncertainties described in the definitive proxy/final prospectus relating to the business combination, which has been filed with the SEC, and in other documents filed by Profusa from time to time with the SEC. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Profusa cannot assure you that the forward-looking statements in this communication will prove to be accurate.
Contacts
Investor and Media Contacts
email: info@coreir.com
phone: 1 (212) 655-0924
FAQ
What did Profusa (PFSA) announce on October 7, 2025?
How much in total did Ascent Partners fund for Profusa's treasury strategy?
Why is Profusa buying digital assets for its treasury (PFSA)?
Will Profusa's digital treasury purchases affect its Lumee development (PFSA)?
When did Profusa make its second $1 million digital asset investment?
